Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/8595
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVozzo, R.en
dc.contributor.authorWittert, G.en
dc.contributor.authorHorowitz, M.en
dc.contributor.authorMorley, J.en
dc.contributor.authorChapman, I.en
dc.date.issued1999en
dc.identifier.citationAmerican Journal of Physiology. Regulatory Integrative and Comparative Physiology, 1999; 276(6):R1562-R1568en
dc.identifier.issn0363-6119en
dc.identifier.issn1522-1490en
dc.identifier.urihttp://hdl.handle.net/2440/8595-
dc.description.abstractAnimal studies suggest that nitric oxide (NO) may be a physiological regulator of appetite; NO synthase (NOS) inhibition suppresses food intake in rats, mice, and chickens. It is not known whether NO has any effect on appetite in humans. We have usedN G-monomethyl-l-arginine (l-NMMA) andN G-nitro-l-arginine methyl ester (l-NAME), both competitive, nonselective inhibitors of NOS, in two separate studies to evaluate the role of NO in the short-term regulation of appetite in humans. Instudy I, 13 men (18–25 yr) underwent paired studies, in randomized, double-blind fashion, after an overnight fast. l-NMMA (4 mg ⋅ kg−1 ⋅ h−1) or saline (0.9%) was infused intravenously at a rate of 40 ml/h for 1.5 h. In study II, eight men (18–26 yr) underwent three randomized, double-blind studies after an overnight fast. l-NAME (75 or 180 μg ⋅ kg−1 ⋅ h−1) or saline (0.9%) was infused intravenously at a rate of 20 ml/h for 120 min. Hunger and fullness were measured using visual analog scales; blood pressure and heart rate were monitored, and 30 min before the end of the infusion, subjects were offered a cold buffet meal. Total caloric intake and the macronutrient composition of the meal were determined. Both l-NMMA (P = 0.052) andl-NAME (P < 0.05; both doses) decreased heart rate, l-NMMA increased diastolic blood pressure (P < 0.01), and l-NAME increased systolic blood pressure (P = 0.052). Neither drug had any effect on caloric intake or sensations of hunger or fullness. Despite having significant effects on cardiovascular function in the doses used, neitherl-NMMA norl-NAME had any effect on feeding, suggesting that NO does not affect short-term appetite or food intake in humans.en
dc.description.statementofresponsibilityRosalie Vozzo, Gary A. Wittert, Michael Horowitz, John E. Morley, and Ian M. Chapmanen
dc.language.isoenen
dc.publisherAmerican Physiological Societyen
dc.rightsCopyright © 1999 the American Physiological Societyen
dc.source.urihttp://ajpregu.physiology.org/content/276/6/R1562en
dc.subjectHumans; NG-Nitroarginine Methyl Ester; omega-N-Methylarginine; Enzyme Inhibitors; Double-Blind Method; Hunger; Appetite; Satiety Response; Blood Pressure; Heart Rate; Eating; Adolescent; Adult; Male; Nitric Oxide Synthaseen
dc.titleEffect of nitric oxide synthase inhibitors on short-term appetite and food intake in humansen
dc.typeJournal articleen
dc.identifier.rmid0030005117en
dc.identifier.doi10.1152/ajpregu.1999.276.6.r1562en
dc.identifier.pubid69123-
pubs.library.collectionMedicine publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidWittert, G. [0000-0001-6818-6065]en
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.